Short-term exposure to air pollution and Mycoplasma pneumoniae infection risk: a distributed lag nonlinear analysis

Zhiping Long1, Zhiping Du1, Liyan Qian1

  • 1Infectious Disease Control Section, Jinhua Center for Disease Control and Prevention, Jinhua, Zhejiang, China.

Abstract

Insights

Short-term exposure to air pollutants like NO₂, PM₁₀, and PM₂.₅ significantly increases Mycoplasma pneumoniae infections, particularly in children. This highlights the need for air quality interventions to reduce infection risk.

Area of Science:

  • Environmental Health
  • Epidemiology
  • Respiratory Infections

Background:

  • Short-term effects of ambient air pollution on Mycoplasma pneumoniae (MP) infections are not well understood.
  • This study investigates the relationship between air pollutants and MP infections in Jinhua, China.

Purpose of the Study:

  • To explore exposure-lag-response associations between key air pollutants and MP infections.
  • To identify specific pollutants and time lags associated with increased MP case counts.

Main Methods:

  • Utilized daily MP case data (2023-2024), air pollutant, and meteorological data.
  • Employed quasi-Poisson regression with distributed lag non-linear models to analyze non-linear and delayed effects of six pollutants.
  • Conducted subgroup analyses based on sex and age, focusing on children (0-14 years).

Main Results:

  • A total of 154,697 MP infections were reported.
  • Nitrogen dioxide (NO₂), carbon monoxide (CO), particulate matter <10 μm (PM₁₀), and particulate matter <2.5 μm (PM₂.₅) showed positive correlations with MP cases.
  • NO₂, PM₁₀, and PM₂.₅ exhibited the strongest effects within 0-7 days, with significant 21-day cumulative risks. Children aged 0-14 years were most susceptible.

Conclusions:

  • Short-term exposure to NO₂, PM₁₀, and PM₂.₅ significantly elevates the risk of MP infections.
  • Children are particularly vulnerable to air pollution-induced MP infections.
  • Findings underscore the importance of targeted air quality interventions to mitigate MP infection risks.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: